Quick Answer
Cytosorbents Corp reported Earnings Per Share Diluted of $0.13 (loss) per share for the year ending 2025.
- Cytosorbents Corp showed an increase of +65.8% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from Cytosorbents Corp's annual report (Form 10-K), filed with the SEC on March 30, 2026.
- XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 7 years of available data (2019 to 2025), Cytosorbents Corp's Earnings Per Share Diluted has grown by 78.3%.
- Historical annual values: Fiscal year 2025: $0.13 (loss) per share | Fiscal year 2024: $0.38 (loss) per share | Fiscal year 2023: $0.65 (loss) per share | Fiscal year 2022: $0.75 (loss) per share | Fiscal year 2021: $0.57 (loss) per share | Fiscal year 2020: $0.20 (loss) per share | Fiscal year 2019: $0.60 (loss) per share.
- Data sourced from SEC EDGAR public filings as of June 21, 2026.
Last verified: